Literature DB >> 16703374

Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora.

Ipek Akil1, Ozge Yilmaz, Semra Kurutepe, Kenan Degerli, Salih Kavukcu.   

Abstract

Enteric flora constitutes 95% of the cells in the human body. It has been shown that the bacterial content of this flora is affected by diet and changes in nutrition. Considering that urinary tract infections (UTI) are mostly due to ascending infections from the gut flora, the importance of the elements of this flora and their characteristics becomes more evident. The aim of this study was to evaluate the influence of oral Saccharomyces boulardii (S. boulardii) intake on the number of Escherichia coli (E. coli) colonies in the colon. This study was carried out with 14 boys and 10 girls (total of 24 children) aged between 36 and 192 months (mean: 104.3+/-45.1 months). A commercial capsule or powder containing 5 billion colony-forming units (cfu) of S. boulardii was administered once a day for 5 days. The number of E. coli and yeast colonies was measured in the stool samples of the study group before and after the use of this drug. Before treatment, the mean number of E. coli colonies in g/ml stool was 384,625+/-445,744. This number decreased significantly to 6,283+/-20,283 after treatment (p=0.00). S. boulardii was not detected in stool before treatment and the number of colonies increased to 11,047+/-26,754 in g/ml stool. S. boulardii may be effective in reducing the number of E. coli colonies in stool. The influence of this finding on clinical practice such as prevention of UTI needs to be clarified by further studies.

Entities:  

Mesh:

Year:  2006        PMID: 16703374     DOI: 10.1007/s00467-006-0088-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  16 in total

1.  Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice.

Authors:  A C Rodrigues; D C Cara; S H Fretez; F Q Cunha; E C Vieira; J R Nicoli; L Q Vieira
Journal:  J Appl Microbiol       Date:  2000-09       Impact factor: 3.772

2.  Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections.

Authors:  G Reid; A W Bruce; M Taylor
Journal:  Clin Ther       Date:  1992 Jan-Feb       Impact factor: 3.393

3.  Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells.

Authors:  D Czerucka; S Dahan; B Mograbi; B Rossi; P Rampal
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries.

Authors:  A B Howell; N Vorsa; A Der Marderosian; L Y Foo
Journal:  N Engl J Med       Date:  1998-10-08       Impact factor: 91.245

Review 5.  In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.

Authors:  C Dunne; L O'Mahony; L Murphy; G Thornton; D Morrissey; S O'Halloran; M Feeney; S Flynn; G Fitzgerald; C Daly; B Kiely; G C O'Sullivan; F Shanahan; J K Collins
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

Review 6.  Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole.

Authors:  Olaf Burkhardt; Thomas Köhnlein; Mathias Pletz; Tobias Welte
Journal:  Scand J Infect Dis       Date:  2005

7.  Clonal diversity of Escherichia coli colonizing stools and urinary tracts of young girls.

Authors:  Theresa A Schlager; J Owen Hendley; Alison L Bell; Thomas S Whittam
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study.

Authors:  Carlo Dani; Roberto Biadaioli; Giovanna Bertini; Elena Martelli; Firmino F Rubaltelli
Journal:  Biol Neonate       Date:  2002-08

9.  Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.

Authors:  Stephanie Dahan; Guillaume Dalmasso; Veronique Imbert; Jean-Francois Peyron; Patrick Rampal; Dorota Czerucka
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

Review 10.  Dietary factors affecting susceptibility to urinary tract infection.

Authors:  Tero Kontiokari; Matti Nuutinen; Matti Uhari
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

View more
  6 in total

Review 1.  Clinical presentation, diagnosis and treatment of vulvovaginitis in girls: a current approach and review of the literature.

Authors:  İlke Beyitler; Salih Kavukcu
Journal:  World J Pediatr       Date:  2016-12-15       Impact factor: 2.764

2.  Saccharomyces boulardii prevents oral-poliovirus vaccine-induced IgA nephropathy in mice.

Authors:  Alper Soylu; Sema Berktaş; Sülen Sarioğlu; Güven Erbil; Osman Yilmaz; Belde K Demir; Yahya Tufan; Didem Yeşilirmak; Mehmet Türkmen; Salih Kavukçu
Journal:  Pediatr Nephrol       Date:  2008-04-30       Impact factor: 3.714

3.  Efficacy of Fluoroquinolone/Probiotic Combination Therapy for Recurrent Urinary Tract Infection in Children: A Retrospective Analysis.

Authors:  Ramiro J Madden-Fuentes; Mehreen Arshad; Sherry S Ross; Patrick C Seed
Journal:  Clin Ther       Date:  2015-07-29       Impact factor: 3.393

Review 4.  Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review.

Authors:  Margret I Moré; Alexander Swidsinski
Journal:  Clin Exp Gastroenterol       Date:  2015-08-14

5.  Management of Pediatric Urinary Tract Infections: A Delphi Study.

Authors:  Giovanni Autore; Luca Bernardi; Claudio La Scola; Filippo Ghidini; Federico Marchetti; Andrea Pasini; Luca Pierantoni; Claudia Castellini; Claudia Gatti; Cristina Malaventura; Gabriella Pelusi; Francesco Antodaro; Andrea Bergomi; Franco Mazzini; Giovanni Parente; Roberto Pillon; Francesca Cusenza; Giacomo Biasucci; Alessandro De Fanti; Lorenzo Iughetti; Serafina Perrone; Andrea Pession; Mario Lima; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-08-18

6.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.